Nanobac Pharmaceuticals Incorporated (NNBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2006 | 06-2006 | 03-2006 | 12-2005 | 09-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,110 | -2,320 | -1,480 | -3,680 | -2,890 |
| Depreciation Amortization | 420 | 300 | 180 | 760 | 560 |
| Other Working Capital | -20 | 60 | 110 | -230 | -270 |
| Other Operating Activity | 800 | 700 | 650 | 790 | 840 |
| Operating Cash Flow | $-1,910 | $-1,260 | $-540 | $-2,360 | $-1,760 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4 | 3 | 3 | -40 | -30 |
| Other Investing Activity | -3 | -3 | -3 | 0 | 0 |
| Investing Cash Flow | $-7 | $0 | $0 | $-40 | $-30 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 2,050 | 1,450 | 1,160 | 2,320 | 1,760 |
| Financing Cash Flow | $2,050 | $1,450 | $1,160 | $2,320 | $1,760 |
| Exchange Rate Effect | -20 | -8 | -6 | 70 | 30 |
| Beginning Cash Position | 9 | 9 | 9 | 10 | 10 |
| End Cash Position | 110 | 180 | 620 | 9 | 10 |
| Net Cash Flow | $100 | $170 | $610 | $-9 | $-6 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,910 | -1,260 | -540 | -2,360 | -1,760 |
| Free Cash Flow | -1,910 | -1,260 | -540 | -2,360 | -1,760 |